ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Alterity Therapeutics Limited

Alterity Therapeutics Limited (ATHE)

5,47
-0,02
( -0,36% )
Aktualisiert: 20:18:01

Alterity Therapeutics Limited (ATHE) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
5,47
( -0,36% )
Gebot
5,30
Fragen
5,64
Volumen
5.201
Durchschnittliches Volumen (3 Mio.)
US$ 168.778
Finanzvolumen
US$ 28.634
5,3302 Tagesbereich 5,70
2,66 52-Wochen-Bereich 7,00
Marktkapitalisierung
Unternehmenswert
96,628M
Handelsende
5,49
Handelsbeginn
5,62
Letzte Trade
4
@
5.5223
Letzter Handelszeitpunkt
20:34:19
VWAP
5,5054
Erlöse (LTM)
6,64M
Nettogewinn (LTM)
-14,59M
Ausgegebene Aktien
217.508.326
Streubesitz (%)
79,46%
Institutioneller Besitz (%)
49,66%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-8,11
Kurs-Umsatz-Verhältnis (KUV)
21,96
Gewinn pro Aktie (EPS)
-0,08
Beta
-0,03

Über Alterity Therapeutics Limited

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical tri... Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Melbourne, Australia
Gegründet
1997
Alterity Therapeutics Limited is listed in the Healthcare sector of the NASDAQ with ticker ATHE. The last closing price for Alterity Therapeutics was US$5,49. Over the last year, Alterity Therapeutics shares have traded in a share price range of US$ 2,66 to US$ 7,00.

Alterity Therapeutics currently has 217.508.326 shares in issue. The market capitalisation of Alterity Therapeutics is US$1,19 billion. Alterity Therapeutics has a price to earnings ratio (PE ratio) of -8.11.

ATHE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.050.9225092250925.425.89225.16229175.5278637DR
41.331.1750599524.175.89223.98303254.93324418DR
121.7948.64130434783.685.89223.63547364.45955682DR
262.267.27828746183.275.89223.0208319024.25875094DR
521.6141.70984455963.8672.66560934.61949986DR
1562.7399.63503649642.7471.0011259494.01212659DR
2603.78223.6686390531.6970.293423861.87566234DR

ATHE - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics Limited share price?
The current share price of Alterity Therapeutics Limited is US$ 5,47
How many Alterity Therapeutics Limited shares are in issue?
Alterity Therapeutics Limited has 217.508.326 shares in issue
What is the market cap of Alterity Therapeutics Limited?
The market capitalisation of Alterity Therapeutics Limited is USD 1,19B
What is the 1 year trading range for Alterity Therapeutics Limited share price?
Alterity Therapeutics Limited has traded in the range of US$ 2,66 to US$ 7,00 during the past year
What is the PE ratio of Alterity Therapeutics Limited?
The price to earnings ratio of Alterity Therapeutics Limited is -8,11
What is the cash to sales ratio of Alterity Therapeutics Limited?
The cash to sales ratio of Alterity Therapeutics Limited is 21,96
What is the registered address of Alterity Therapeutics Limited?
The registered address for Alterity Therapeutics Limited is 500 Collins Street, Melbourne, Victoria, 3000
What is the Alterity Therapeutics Limited website address?
The website address for Alterity Therapeutics Limited is alteritytherapeutics.com
Which industry sector does Alterity Therapeutics Limited operate in?
Alterity Therapeutics Limited operates in the Biotechnology & Life Sciences sector

ATHE Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen